7UVQ image
Entry Detail
PDB ID:
7UVQ
Title:
Pfs230 domain 1 bound by RUPA-97 and 15C5 Fabs
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2022-05-02
Release Date:
2023-02-15
Method Details:
Experimental Method:
Resolution:
3.29 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 62
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Gametocyte surface protein P230
Chain IDs:A
Chain Length:199
Number of Molecules:1
Biological Source:Plasmodium falciparum
Polymer Type:polypeptide(L)
Description:Fab Kappa Light Chain
Chain IDs:B
Chain Length:213
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Fab Heavy Chain
Chain IDs:C
Chain Length:221
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Fab Heavy Chain
Chain IDs:D
Chain Length:227
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Fab Kappa Light Chain
Chain IDs:E
Chain Length:215
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.
Immunity 56 420 432.e7 (2023)
PMID: 36792575 DOI: 10.1016/j.immuni.2023.01.013

Abstact

Pfs230 is essential for Plasmodium falciparum transmission to mosquitoes and is the protein targeted by the most advanced malaria-transmission-blocking vaccine candidate. Prior understanding of functional epitopes on Pfs230 is based on two monoclonal antibodies (mAbs) with moderate transmission-reducing activity (TRA), elicited from subunit immunization. Here, we screened the B cell repertoire of two naturally exposed individuals possessing serum TRA and identified five potent mAbs from sixteen Pfs230 domain-1-specific mAbs. Structures of three potent and three low-activity antibodies bound to Pfs230 domain 1 revealed four distinct epitopes. Highly potent mAbs from natural infection recognized a common conformational epitope that is highly conserved across P. falciparum field isolates, while antibodies with negligible TRA derived from natural infection or immunization recognized three distinct sites. Our study provides molecular blueprints describing P. falciparum TRA, informed by contrasting potent and non-functional epitopes elicited by natural exposure and vaccination.

Legend

Protein

Chemical

Disease

Primary Citation of related structures